Developing an In-House Comprehensive Medication Review Training Program for Clinical Pharmacists in a Finnish Hospital Pharmacy

Kvarnström, Kirsi; Niittynen, Ilona; Kallio, Sonja; Linden-Lahti, Carita; Airaksinen, Marja; Schepel, Lotta

doi:10.3390/ijerph20126158

Cited by 3 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In HUS' earlier EHR system, it was easier to skip this step, which led to major discrepancies in the prior-to-admission/home medication list [53]. With the new EHR system, these errors are no longer hidden, and clinical pharmacists are a widely involved and appreciated resource for conducting medication reconciliations [10,54]. However, this more structured process is laborious, and the nationwide development of the Kanta system holding updated structured home medication lists in addition to electronic outpatient prescriptions [35] should be done urgently to save time and resources without risking medication safety [10].…”

Section: Medication Reconciliationmentioning

confidence: 99%

Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish Hospitals

Shermock,

Schepel

2023

IJERPH

View full text Add to dashboard Cite

Many medication errors in the hospital setting are due to manual, error-prone processes in the medication management system. Closed-loop Electronic Medication Management Systems (EMMSs) use technology to prevent medication errors by replacing manual steps with automated, electronic ones. As Finnish Helsinki University Hospital (HUS) establishes its first closed-loop EMMS with the new Epic-based Electronic Health Record system (APOTTI), it is helpful to consider the history of a more mature system: that of the United States. The U.S. approach evolved over time under unique policy, economic, and legal circumstances. Closed-loop EMMSs have arrived in many U.S. hospital locations, with myriad market-by-market manifestations typical of the U.S. healthcare system. This review describes and compares U.S. and Finnish hospitals’ EMMS approaches and their impact on medication workflows and safety. Specifically, commonalities and nuanced differences in closed-loop EMMSs are explored from the perspectives of the care/nursing unit and hospital pharmacy operations perspectives. As the technologies are now fully implemented and destined for evolution in both countries, perhaps closed-loop EMMSs can be a topic of continued collaboration between the two countries. This review can also be used for benchmarking in other countries developing closed-loop EMMSs.

show abstract

Section: Medication Reconciliationmentioning

confidence: 99%

Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish Hospitals

Shermock,

Schepel

2023

IJERPH

View full text Add to dashboard Cite

show abstract

“…A systematic review presenting various tools and methods in oncology is reported by Whitman et al [19]. Interestingly, it can be implemented as part of research projects in Proactive Pharmacovigilance, or it can be a service of normal clinical practice exercised by structured health care personnel [20,21].…”

Section: Introductionmentioning

confidence: 99%

Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports

Orzetti,

Baldo

2023

IJMS

View full text Add to dashboard Cite

The use of natural compounds and, in general, the use of Complementary and Alternative Medicine (CAM), is growing steadily worldwide, both due to commercial pressure and the increasing use of self-medication and the desire to manage one’s own personal health and well-being. Patients facing a cancer diagnosis are also strongly pressured to use these compounds, which are often added to standard therapeutic regimens, that should instead be based solely on diagnostic and therapeutic care pathways (DTCP) or evidence-based medicine (EBM). This study presents two clinical cases of cancer patients who presented to the pharmaceutical consultation service (PCD—Pharmacy Clinical Desk) established at the CRO Institute in Aviano, Italy. Both patients were using natural products along with prescribed chemotherapy. In the first case, a 55-year-old woman diagnosed with bilateral breast cancer with bone metastases, who was using natural compounds based on diosmin, escin (or aescin) and resveratrol in combination with ribociclib anticancer therapy, a severe ADR (neutropenia) was identified as a consequence of the drug–natural product interaction. In the second case, following a detailed medication review by the PCD, we avoided taking a therapeutic treatment (with natural compounds) that in itself could potentially render chemotherapy ineffective in a 57-year-old woman with multiple infiltrating ductal carcinoma of the left breast; the patient was planning to take a natural product containing St. John’s Wort tincture and lemon balm tincture, in combination with paclitaxel and trastuzumab. In addition, we describe the corrective actions taken, thus outlining the main objectives of the activity of the PCD’s pharmacy counseling service: first, to identify, report, and manage adverse drug reactions (ADRs), and second, to identify therapeutic combinations that present potential risks of toxicity or ineffectiveness of the drug therapy itself.

show abstract

Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey

Schepel,

Kunnola,

Airaksinen

et al. 2024

Eur J Hosp Pharm

View full text Add to dashboard Cite

Developing an In-House Comprehensive Medication Review Training Program for Clinical Pharmacists in a Finnish Hospital Pharmacy

Cited by 3 publications

References 28 publications

Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish Hospitals

Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish Hospitals

Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports

Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey

Contact Info

Product

Resources

About